| Year |
Citation |
Score |
| 2023 |
Tringali G, Pizzoferrato M, Lisi L, Marinelli S, Buccarello L, Falsini B, Cattaneo A, Navarra P. A Vicious NGF-p75 Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19. International Journal of Molecular Sciences. 24. PMID 38003427 DOI: 10.3390/ijms242216237 |
0.495 |
|
| 2023 |
Lisi L, Pizzoferrato M, Ciotti GMP, Martire M, Navarra P. mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models. International Journal of Molecular Sciences. 24. PMID 37372982 DOI: 10.3390/ijms24129834 |
0.535 |
|
| 2023 |
De Pascale G, Pintaudi G, Lisi L, De Maio F, Cutuli SL, Tanzarella ES, Carelli S, Lombardi G, Cesarano M, Gennenzi V, Ciotti GMP, Grieco DL, Posteraro B, Sanguinetti M, Navarra P, et al. Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible VAP: Clinical, Pharmacokinetic and Microbiome Features. Antibiotics (Basel, Switzerland). 12. PMID 36671325 DOI: 10.3390/antibiotics12010125 |
0.426 |
|
| 2022 |
Lisi L, Marinelli S, Ciotti GMP, Pizzoferrato M, Palmerio F, Chiavari M, Cattaneo A, Navarra P. The effects of painless nerve growth factor on human microglia polarization. Frontiers in Cellular Neuroscience. 16: 969058. PMID 36339818 DOI: 10.3389/fncel.2022.969058 |
0.48 |
|
| 2022 |
Lisi L, Ciotti GMP, Chiavari M, Martire M, Navarra P. The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF. Growth Factors (Chur, Switzerland). 1-9. PMID 35442129 DOI: 10.1080/08977194.2022.2060095 |
0.468 |
|
| 2022 |
Graziani G, Lisi L, Tentori L, Navarra P. Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab. Experientia Supplementum (2012). 113: 295-350. PMID 35165868 DOI: 10.1007/978-3-030-91311-3_10 |
0.488 |
|
| 2022 |
Lisi L, Lacal PM, Martire M, Navarra P, Graziani G. Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment. Pharmacological Research. 175: 105997. PMID 34826600 DOI: 10.1016/j.phrs.2021.105997 |
0.487 |
|
| 2020 |
Chiavari M, Ciotti GMP, Canonico F, Altieri F, Lacal PM, Graziani G, Navarra P, Lisi L. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation. International Journal of Molecular Sciences. 21. PMID 33153019 DOI: 10.3390/ijms21218214 |
0.563 |
|
| 2020 |
Cutuli SL, De Pascale G, Lisi L, Carelli S, Navarra P, Antonelli M. Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda. Annals of Intensive Care. 10: 141. PMID 33052543 DOI: 10.1186/s13613-020-00759-4 |
0.392 |
|
| 2020 |
Lisi L, Lacal PM, Barbaccia ML, Graziani G. Approaching Coronavirus Disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Biochemical Pharmacology. 114169. PMID 32710969 DOI: 10.1016/J.Bcp.2020.114169 |
0.32 |
|
| 2020 |
De Pascale G, Lisi L, Ciotti GMP, Vallecoccia MS, Cutuli SL, Cascarano L, Gelormini C, Bello G, Montini L, Carelli S, Di Gravio V, Tumbarello M, Sanguinetti M, Navarra P, Antonelli M. Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections. Annals of Intensive Care. 10: 94. PMID 32661791 DOI: 10.1186/S13613-020-00715-2 |
0.466 |
|
| 2020 |
Lisi L, Pia Ciotti GM, Chiavari M, Ruffini F, Lacal PM, Graziani G, Navarra P. Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages. Oncology Reports. PMID 32236632 DOI: 10.3892/Or.2020.7553 |
0.552 |
|
| 2020 |
Lisi L, Chiavari M, Ciotti GMP, Lacal PM, Navarra P, Graziani G. DNA inhibitors for the treatment of brain tumors. Expert Opinion On Drug Metabolism & Toxicology. PMID 32067518 DOI: 10.1080/17425255.2020.1729352 |
0.544 |
|
| 2019 |
Moutal A, Kalinin S, Kowal K, Marangoni N, Dupree J, Lin SX, Lis K, Lisi L, Hensley K, Khanna R, Feinstein DL. Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis. Asn Neuro. 11: 1759091419892090. PMID 31795726 DOI: 10.1177/1759091419892090 |
0.514 |
|
| 2019 |
Lisi L, Pia Ciotti GM, Chiavari M, Pizzoferrato M, Mangiola A, Kalinin S, Feinstein DL, Navarra P. Phospho-mTOR expression in human glioblastoma microglia-macrophage cells. Neurochemistry International. 104485. PMID 31195027 DOI: 10.1016/J.Neuint.2019.104485 |
0.693 |
|
| 2019 |
Chiavari M, Ciotti GMP, Navarra P, Lisi L. Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line. Brain Sciences. 9. PMID 31096716 DOI: 10.3390/Brainsci9050111 |
0.57 |
|
| 2018 |
Kalinin S, González-Prieto M, Scheiblich H, Lisi L, Kusumo H, Heneka MT, Madrigal JLM, Pandey SC, Feinstein DL. Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis. Journal of Neuroinflammation. 15: 141. PMID 29759078 DOI: 10.1186/S12974-018-1184-7 |
0.527 |
|
| 2017 |
Rossetti B, Gagliardini R, Meini G, Sterrantino G, Colangeli V, Re MC, Latini A, Colafigli M, Vignale F, Rusconi S, Micheli V, Di Biagio A, Orofino G, Ghisetti V, Fantauzzi A, ... ... Lisi L, et al. Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. Plos One. 12: e0187393. PMID 29161288 DOI: 10.1371/Journal.Pone.0187393 |
0.476 |
|
| 2017 |
Atzori MG, Tentori L, Ruffini F, Ceci C, Lisi L, Bonanno E, Scimeca M, Eskilsson E, Daubon T, Miletic H, Ricci Vitiani L, Pallini R, Navarra P, Bjerkvig R, D'Atri S, et al. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells. Journal of Experimental & Clinical Cancer Research : Cr. 36: 106. PMID 28797294 DOI: 10.1186/S13046-017-0577-2 |
0.501 |
|
| 2017 |
Lisi L, Pizzoferrato M, Miscioscia FT, Topai A, Navarra P. Interactions between Integrase Inhibitors and human Arginase 1. Journal of Neurochemistry. PMID 28397245 DOI: 10.1111/Jnc.14039 |
0.571 |
|
| 2017 |
Laudati E, Currò D, Navarra P, Lisi L. Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm. Neurochemistry International. PMID 28279751 DOI: 10.1016/J.Neuint.2017.03.002 |
0.589 |
|
| 2017 |
Lisi L, Ciotti GM, Braun D, Kalinin S, Currò D, Dello Russo C, Coli A, Mangiola A, Anile C, Feinstein DL, Navarra P. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma. Neuroscience Letters. 645: 106-112. PMID 28259657 DOI: 10.1016/J.Neulet.2017.02.076 |
0.74 |
|
| 2017 |
Lisi L, Graziani G, Navarra P. Macrophages/microglia in glioblastoma: a Zelig-like story of changing phenotypes Translational Cancer Research. 6. DOI: 10.21037/15144 |
0.541 |
|
| 2016 |
Dello Russo C, Lisi L, Tentori L, Navarra P, Graziani G, Combs CK. Exploiting Microglial Functions for the Treatment of Glioblastoma. Current Cancer Drug Targets. PMID 27528361 DOI: 10.2174/1568009616666160813191240 |
0.708 |
|
| 2016 |
Ciucci A, Zannoni GF, Buttarelli M, Lisi L, Travaglia D, Martinelli E, Scambia G, Gallo D. Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers. Oncotarget. PMID 26797759 DOI: 10.18632/Oncotarget.6943 |
0.326 |
|
| 2015 |
Lisi L, Laudati E, Miscioscia TF, Dello Russo C, Topai A, Navarra P. Antiretrovirals inhibit arginase in human microglia. Journal of Neurochemistry. PMID 26466119 DOI: 10.1111/Jnc.13393 |
0.728 |
|
| 2015 |
Pozzoli G, De Simone ML, Cantalupo E, Cenciarelli C, Lisi L, Boninsegna A, Dello Russo C, Sgambato A, Navarra P. The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation. Molecular and Cellular Endocrinology. 412: 205-15. PMID 25960164 DOI: 10.1016/J.Mce.2015.05.004 |
0.72 |
|
| 2015 |
Lisi L, Aceto P, Navarra P, Dello Russo C. mTOR kinase: a possible pharmacological target in the management of chronic pain. Biomed Research International. 2015: 394257. PMID 25685786 DOI: 10.1155/2015/394257 |
0.674 |
|
| 2015 |
Scarsi C, Levesque A, Lisi L, Navarra P. The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 96: 11-6. PMID 25559240 DOI: 10.1016/J.Plefa.2014.12.006 |
0.472 |
|
| 2014 |
Imberti R, De Gregori S, Lisi L, Navarra P. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm. Pharmacology. 94: 143-7. PMID 25277061 DOI: 10.1159/000367663 |
0.507 |
|
| 2014 |
Lisi L, Laudati E, Navarra P, Dello Russo C. The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype. Journal of Neuroinflammation. 11: 125. PMID 25051975 DOI: 10.1186/1742-2094-11-125 |
0.736 |
|
| 2014 |
Romani F, Tropea A, Scarinci E, Federico A, Dello Russo C, Lisi L, Catino S, Lanzone A, Apa R. Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells. Fertility and Sterility. 102: 831-7. PMID 25016925 DOI: 10.1016/J.Fertnstert.2014.05.041 |
0.638 |
|
| 2014 |
Lisi L, Stigliano E, Lauriola L, Navarra P, Dello Russo C. Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells. Asn Neuro. 6: 171-83. PMID 24689533 DOI: 10.1042/An20130045 |
0.737 |
|
| 2014 |
Greco MC, Lisi L, Currò D, Navarra P, Tringali G. Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro. Peptides. 56: 8-13. PMID 24662320 DOI: 10.1016/J.Peptides.2014.03.009 |
0.523 |
|
| 2014 |
Dello Russo C, Lisi L, Fabbiani M, Gagliardi D, Fanti I, Di Giambenedetto S, Cauda R, Navarra P. Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data. Pharmacogenomics. 15: 319-27. PMID 24533711 DOI: 10.2217/Pgs.13.242 |
0.666 |
|
| 2014 |
Lisi L, Tramutola A, Navarra P, Dello Russo C. Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism. Journal of Neuroimmunology. 266: 24-32. PMID 24268674 DOI: 10.1016/J.Jneuroim.2013.10.013 |
0.728 |
|
| 2013 |
Fortuna S, Fabbiani M, Digiambenedetto S, Ragazzoni E, Lisi L, Cauda R, Navarra P. Variability of raltegravir plasma levels in the clinical setting. Pharmacology. 92: 43-8. PMID 23887354 DOI: 10.1159/000351851 |
0.493 |
|
| 2013 |
Romani F, Tropea A, Scarinci E, Dello Russo C, Lisi L, Catino S, Lanzone A, Apa R. Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews. 31: 170-80. PMID 23672405 DOI: 10.1080/10590501.2013.782180 |
0.618 |
|
| 2013 |
Ciucci A, De Stefano I, Vellone VG, Lisi L, Bottoni C, Scambia G, Zannoni GF, Gallo D. Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. Plos One. 8: e60145. PMID 23555905 DOI: 10.1371/Journal.Pone.0060145 |
0.353 |
|
| 2013 |
Fortuna S, Ragazzoni E, Lisi L, Di Giambenedetto S, Fabbiani M, Navarra P. Validation of an UPLC-MS/MS method for quantitative analysis of raltegravir in human plasma samples. Therapeutic Drug Monitoring. 35: 258-63. PMID 23407478 DOI: 10.1097/Ftd.0B013E318280110D |
0.47 |
|
| 2013 |
Lisi L, Camardese G, Treglia M, Tringali G, Carrozza C, Janiri L, Dello Russo C, Navarra P. Monocytes from depressed patients display an altered pattern of response to endotoxin challenge. Plos One. 8: e52585. PMID 23300980 DOI: 10.1371/Journal.Pone.0052585 |
0.7 |
|
| 2013 |
Lisi L, McGuire S, Sharp A, Chiosis G, Navarra P, Feinstein DL, Dello Russo C. The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. Journal of Neuroimmunology. 255: 1-7. PMID 23123171 DOI: 10.1016/J.Jneuroim.2012.10.008 |
0.749 |
|
| 2013 |
Dello Russo C, Lisi L, Feinstein DL, Navarra P. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. 61: 301-11. PMID 23044764 DOI: 10.1002/Glia.22433 |
0.759 |
|
| 2012 |
Tringali G, Greco MC, Lisi L, Pozzoli G, Navarra P. Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. Peptides. 34: 353-9. PMID 22342595 DOI: 10.1016/J.Peptides.2012.02.004 |
0.54 |
|
| 2012 |
Lisi L, Navarra P, Cirocchi R, Sharp A, Stigliano E, Feinstein DL, Dello Russo C. Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 243: 43-51. PMID 22264993 DOI: 10.1016/J.Jneuroim.2011.12.018 |
0.736 |
|
| 2012 |
Lisi L, Tramutola A, De Luca A, Navarra P, Dello Russo C. Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120. Journal of Neurochemistry. 120: 106-14. PMID 22017448 DOI: 10.1111/J.1471-4159.2011.07549.X |
0.715 |
|
| 2011 |
De Corato A, Lisi L, Capuano A, Tringali G, Tramutola A, Navarra P, Dello Russo C. Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. Journal of Neuroimmunology. 237: 39-46. PMID 21719118 DOI: 10.1016/J.Jneuroim.2011.05.013 |
0.716 |
|
| 2011 |
Dello Russo C, Lisi L, Lofaro A, Di Giambenedetto S, Federico B, Madeddu G, Salerno M, Mura MS, Pirazzoli A, de Luca A, Cauda R, Navarra P. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR. Pharmacogenomics. 12: 567-76. PMID 21521028 DOI: 10.2217/Pgs.10.208 |
0.663 |
|
| 2011 |
Lin SX, Lisi L, Dello Russo C, Polak PE, Sharp A, Weinberg G, Kalinin S, Feinstein DL. The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. Asn Neuro. 3. PMID 21382015 DOI: 10.1042/An20100033 |
0.73 |
|
| 2011 |
Lisi L, Navarra P, Feinstein DL, Dello Russo C. The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. Journal of Neuroinflammation. 8: 1. PMID 21208419 DOI: 10.1186/1742-2094-8-1 |
0.768 |
|
| 2009 |
Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Molecular Pain. 5: 43. PMID 19660121 DOI: 10.1186/1744-8069-5-43 |
0.716 |
|
| 2009 |
Dello Russo C, Lisi L, Tringali G, Navarra P. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochemical Pharmacology. 78: 1242-51. PMID 19576187 DOI: 10.1016/J.Bcp.2009.06.097 |
0.745 |
|
| 2009 |
Dello Russo C, Lisi L, Navarra P, Tringali G. Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes. Journal of Neuroimmunology. 213: 78-83. PMID 19552966 DOI: 10.1016/J.Jneuroim.2009.05.016 |
0.699 |
|
| 2009 |
Tringali G, Lisi L, De Simone ML, Aubry JM, Preziosi P, Pozzoli G, Navarra P. Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1017-21. PMID 19467289 DOI: 10.1016/J.Pnpbp.2009.05.012 |
0.52 |
|
| 2008 |
Tringali G, Lisi L, Bettella F, Renier D, Di Stasi SM, Navarra P. The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 58: 340-3. PMID 18848989 DOI: 10.1016/J.Phrs.2008.09.008 |
0.499 |
|
| 2007 |
Tringali G, Pozzoli G, Lisi L, Navarra P. Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism. Endocrinology. 148: 4711-5. PMID 17615151 DOI: 10.1210/En.2007-0431 |
0.544 |
|
| Show low-probability matches. |